Intraluminal stenting of the small bowel has been advocated as a method of reducing the risk of recurrent adhesional obstruction in patients requiring adhesolysis. We reviewed the complications and efficacy of this technique in 25 patients undergoing surgery for relief of intestinal obstruction due to complex, extensive and dense adhesions.
INTRODUCTION
Adhesions account for 30-40% of cases of intestinal obstruction in the Western world1'2. Although most patients presenting with clinical and radiological features ofadhesional obstruction recover with non-operative management, up to 30% require surgical intervention1. After successful relief of obstruction by adhesolysis, there is no proven method to prevent formation of further adhesions postoperatively and a small number of patients are plagued by recurrent obstruction. The need for repeated laparotomies in such patients can pose great technical difficulties for the surgeon and may be hazardous for the patient.
Intraluminal stenting of the small bowel after adhesolysis was originally described by White in 19563 as a possible way to maintain small bowel patency while fresh adhesions form, thereby reducing the risk of subsequent adhesional obstruction. In Britain the procedure was modified by Munro and Jones4, who described encouraging results, but intraluminal stenting never gained widespread popularity. We have reviewed the results of intraluminal stenting in a series of patients with adhesional obstruction, treated over 11 years in a district general hospital surgical department.
PATIENTS AND METHODS
Review of operating theatre log books and patient discharge letters identified 25 patients (19 M: 6 F) with a mean age of 38 years (range 10-72 years). All patients presented with clinical and radiological features of established small bowel obstruction. When they did not settle with conservative management, laparotomy revealed extensive, dense adhesions as the cause of obstruction.
Before the laparotomy at which stenting was performed, all 25 patients had undergone at least one previous abdominal operation, which in most cases involved surgery to viscera within the infracolic compartment (Table 1) . 10 patients had undergone additional abdominal operations for non-obstructive conditions before first presenting with adhesional small bowel obstruction. Six patients first developed adhesional obstruction within 28 days of their initial abdominal operation ( Table  2 ). Most of the remaining patients presented with their first episode of adhesional obstruction within 5 years of initial surgery, but three patients presented after 7, 8, and 25 years.
Before management by intraluminal stenting, 19 (76%) of the patients had had episodes of small bowel obstruction necessitating hospital admission and 15 (60%) had required laparotomy and adhesolysis for its relief on at least one occasion ( Table 3 ). Of the 6 remaining patients who underwent intraluminal stenting at the time of their first episode of adhesional obstruction, 2 had become obstructed within 7 days of preceding surgery and a further three had developed obstruction within 12 months of a previous operation.
At operation, all adhesions were divided so as completely to free the entire length of the small bowel. A 3 m 18Ch tube stent with side perforations and a 5 m balloon at the distal end (Jones Intestinal Tube: Franklin Medical) was then introduced through the abdominal wall and into the gastrointestinal tract via a gastrostomy (six patients) or Witzel jejunostomy (19) . The stent was advanced along the small bowel so that its distal end passed into the caecum (or out through the ileostomy in patients who had previously undergone colectomy). The balloon was inflated and the small bowel was arranged into an orderly series of open loops and replaced in the abdomen.
Patients were managed postoperatively with intravenous fluids until the return of normal bowel motility, when oral fluids and nutrition were gradually reintroduced. The tube stent was left on free drainage initially, to provide a route for decompression of the small bowel. It was spigotted when normal bowel motility had returned and was removed after a mean of 10.6 days (range 7-30 days), on the ward, under intravenous sedation with diazepam.
The patients' records were reviewed to identify postoperative complications that had occurred after use of the intraluminal stent. All surviving patients (n=23) were reviewed in clinic or contacted by postal questionnaire to 
RESULTS

Deaths and complications
There were no deaths during the perioperative period. Two patients have died since: the first, a 33-year-old man, died 12 months later with cerebral metastases from oesophageal carcinoma; the second, a 21-year-old man, re-presented 2 months after stenting with chronic small bowel dilatation, weight loss and intermittent vomiting (though not absolute constipation) and died 6 months later from massive pulmonary embolism. Neither contrast studies before death nor post mortem examination showed evidence of mechanical small bowel obstruction, although extensive adhesions around the ileum were found at necropsy. Eight patients (32%) developed postoperative complications (Table 4 ) after intraluminal stenting. In five these were minor and did not delay hospital discharge. Three, however, had major complications-a pelvic abscess requiring surgical drainage in one, and enterocutaneous fistulae necessitating parenteral feeding in two. In one patient, the fistula closed spontaneously after 6 weeks, but the second had to be referred for longer term parenteral feeding because of several high-output fistulae through the main abdominal wound. At mean follow-up of 54 months (range 24-120), 20 (87%) of the 23 patients still alive have remained free of recurrent obstruction. Three patients (13%) have had documented episodes of recurrent intestinal obstruction, necessitating hospital admission and treatment. The timing and number of recurrent obstructive episodes in these three surviving patients are shown in Table 5 . All obstructive episodes settled with conservative management and none of the patients has required further surgical intervention.
DISCUSSION
The aims of surgical intervention in the management of small bowel obstruction are to decompress the intestine, prevent ischaemic infarction secondary to increasing wall tension (LaPlace's law), relieve the obstruction, and wherever possible prevent subsequent episodes of obstructions. Whilst the first three can be achieved satisfactorily by adhesolysis in patients with adhesional obstruction, up to 20% of patients who undergo adhesolysis alone will require future hospital admission for the management of recurrent obstructive episodesv8. Surgical techniques designed to reduce the risk of recurrent obstruction after adhesolysis have concentrated on encouraging adhesions to form in a controlled manner with the small bowel held in a non-obstructed configuration. Both the original suture plication procedure of Noble9 and the modified technique of transmesenteric plication described by Childs and Within the group of patients reported here, many of whom had complex past histories of adhesional obstruction, intraluminal stenting seemed to prevent reobstruction, in that 20 of 23 had no further episodes. The results are inferior to those originally reported by Munro and Jones, who found no complications or failures in 32 patients. Their mean follow-up, however, was 2.5 years, whereas ours was 4.5 years, and all three patients with reobstruction first represented at least 3 years after stenting. Other groups have reported reobstruction rates similar to ours (between 8% and 32%) with longer follow-up6,7,14 16 (Table 5 ).
In retrospective series, comparison of the results of stenting with those of adhesolysis alone is prone to inaccuracy because of differences in patient selection. In most studies, as in ours, stenting has been used largely in patients with complex histories of adhesional obstruction and/or severe patterns of adhesions, who may be at higher risk of reobstruction than those with single bands or less dense adhesions. However, studies reporting the rate of reobstruction following simple adhesolysis have generally included patients with all grades and densities of adhesions. The reobstruction rates of 0-30% reported in this and previous studies do not show an obvious advantage over the rates of 11-13% reported after adhesolysis6-8, but neither do they prove that the procedure is of no value.
To establish the true value of intraluminal stenting would require a randomized trial. Until that can be done, should the technique be used at all? Even if it is effective, one must consider the complications. In our series the intra-abdominal sepsis and fistula formation might have resulted not from stent insertion but from unrecognized or inadequately repaired small bowel perforation, occurring during adhesolysis. However, postoperative enterocutaneous fistulae have been reported by others who have used intraluminal stentsl5,17 with the suggestion that they cause pressure necrosis of the small bowel walll5. Withdrawal of the intraluminal stent may also be a potential source of trauma, particularly if excessive traction is applied. Other complications appear more clearly associated with the jejunal route of stent insertion, including infection or prolonged drainage from the jejunostomy site following tube removal, as observed in three of our own patients, or obstruction at the jejunostomy site and intussusception as previously reported by others15,17,18. Insertion of the tube stent via a gastrostomy has been suggested as a safer method of intubation5 and this route was employed in six patients in the present study; however, intra-operative difficulties and postoperative complications, including high-volume fluid output and persistent gastrocutaneous fistulation, have been described with this mode of stent introduction19. It is noteworthy, however, that the overall complication rate associated with intraluminal stenting seems much lower than that seen with either suture plication or transmesenteric plication 1,12
The value of intraluminal stenting in the prevention of adhesional small bowel reobstruction remains unproven. In view of the serious complications seen in this and previous studies, use of intraluminal stenting cannot be supported as a prophylactic measure, as has been advocated previously4, nor can its routine use as a therapeutic manoeuvre be advised in patients undergoing their first laparotomy for relief of adhesional obstruction or in those with obstruction due to single bands or minor patterns of adhesions.
